All three cholinesterase inhibitors work in a similar way, but one might be better for someone than another. For instance, a person may have fewer side effects from one. Eventually, the disease will ...
Currently approved drugs for AD target cholinesterase, to reduce acetylcholine degradation, and N-methyl-D-aspartate (NMDA) receptors, to prevent excitotoxicity, but they have limited effects on ...
Cholinesterase inhibitors prevent the breakdown ... chemical are low in the brains of people with AD. The use of these drugs can partially correct the deficit. The three ChEIs now available ...
This medication is a local anesthetic used to ... (Contraindications) Hypersensitivity, complete heart block, low plasma-cholinesterase concentrations, pyrogenic infection at or near the skin.
Some of the most commonly used drugs in dementia are cholinesterase inhibitors, which prevent the breakdown of acetylcholine, a neurotransmitter involved in learning and memory. Common ...